Outcomes After Tracheal Cannula Removal
Launched by KATHARINA WINIKER · Sep 18, 2023
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how patients manage after having their tracheostomy tube removed, a procedure known as decannulation. The study is taking place at the Swiss Paraplegic Centre in Nottwil and aims to gather information from patients who have had this procedure to improve care for future patients. The researchers will work closely with various stakeholders, including healthcare providers and patients, to understand the outcomes and experiences related to this process.
To participate in the study, you need to be an adult patient (18 years or older) who has had a tracheostomy and is currently receiving care at the Swiss Paraplegic Centre. You will also need to be able to communicate in German, French, Italian, or English and provide consent to join the study. If you are someone who has had their tracheostomy tube removed during the study period, you may be eligible. Participants can expect to contribute to important research that could help improve care for others in the future. It's important to know that if you are not planning to have your tube removed or are being treated elsewhere for this, you would not be eligible for this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • at the time of recruitment, tracheotomized adult in-patients (≥ 18 years) of the SPC with any medical diagnosis
- • decannulated in the Swiss Paraplegic Center Nottwil within the project's data collection period
- • German, French, Italian or English as communication language
- • study consent
- Exclusion Criteria:
- • patients for whom no decannulation is sought (e.g., due to degenerative illness)
- • patients for whom decannulation is planned in a clinic other than the SPC (e.g., patients hospitalized in the SPC for weaning only)
About Katharina Winiker
Katharina Winiker is a dedicated clinical trial sponsor with a commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic solutions, she leads a team that specializes in designing and executing clinical trials across various therapeutic areas. Katharina's expertise in regulatory compliance, patient recruitment, and data integrity ensures that each study is conducted with the highest ethical standards and scientific rigor. By fostering collaborations with healthcare professionals and research institutions, she aims to bring groundbreaking treatments from the lab to the clinic, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nottwil, Luzern, Switzerland
Patients applied
Trial Officials
Katharina Winiker, PhD
Principal Investigator
Swiss University of Speech and Language Sciences
Gabi Müller Verbiest, PhD
Study Chair
Swiss Paraplegic Center Nottwil
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported